Patterns of illicit drug use vary widely around the world. For example, one recent survey [1] found lifetime cannabis use among 41.9% of respondents in New Zealand, but only 6.6% of respondents in Italy and 1.5% in Japan. Cocaine was reported by 16.2% of respondents in the USA, versus 4.1% in Spain and 0.0% in the People's Republic of China. Favored drugs of abuse may also rank differently within different countries. Japan, for instance, has experienced three major epidemics of methamphetamine abuse over the last 50 years [2, 3], but shows a low prevalence of many other forms of drug abuse that are widespread elsewhere [4]. Clearly, factors such as drug availability, government enforcement policies and national healthcare systems contribute to these figures, but one must also acknowledge the critical role of culture [5]. Culture influences not only attitudes towards illicit drug use in general, but also which particular drugs people choose to use; a drug effect sought by one population might have little appeal for another. As one example of this little-studied issue, we explore here a form of drug abuse that is strikingly asymmetric across cultures: the use of ‘body image drugs’ such as anabolic-androgenic steroids (AAS).
The AAS are a family of hormones that includes the natural male hormone testosterone and its numerous synthetic derivatives [6]. In high doses, AAS permit users (who are mostly [7], though not always [8], male) to achieve marked increases in muscularity and decreases in body fat, often well beyond the limits attainable by natural means [9] (fig. 1). Prior to about 1980, AAS use was primarily confined to elite competitive athletes, but in the last 30 years, these drugs have spread into the general population [10]. Now, AAS have been used worldwide by millions of men, many of whom have no athletic aspirations, but simply want to look more muscular [6, 11]. Such men often also use various other body image drugs to gain muscle or lose body fat [12], including substances such as human growth hormone, thyroid hormones, insulin, clenbuterol and ephedrine [13, 14]. At present, however, most of the available epidemiological data are confined to AAS. Concern about the dangers of these drugs has mounted over the last decade [10], with increasing recognition of their possible cardiac [13, 15], neuroendocrine [6] and psychiatric effects [16], including the frequent development of dependence syndromes [17, 18, 19].
Fig. 1.
a Photograph of Eugene Sandow, a famous bodybuilder from the era prior to AAS, showing the approximate maximum muscularity attainable without AAS. http://commons.wikimedia.org/wiki/File:Eugene_Sandow.jpg (accessed June 12, 2011). b A modern bodybuilder who has extensively used AAS.
The prevalence of AAS use shows striking geographic variation. AAS abuse is a particularly common problem in Scandinavia [20, 21, 22, 23], followed perhaps next by the USA [24, 25], then the British Commonwealth countries [26, 27, 28, 29, 30], Brazil [31] and the rest of Western Europe [32, 33, 34]. By contrast, AAS abuse is rare in the Far East, with only a handful of reports of illicit AAS use in countries such as China, Korea or Japan [35, 36, 37, 38]. Indeed, in a recent study where we administered questionnaires to 118 Chinese men aged 21–38 years at a Beijing graduate school [39], none reported having ever used AAS or having even known of an acquaintance who had, even though AAS are legally available over the counter in Beijing pharmacies. Contrast this finding with Norway, where AAS are illegal, yet 28% of teenage students in one study knew an acquaintance who had used these drugs [21]. Admittedly, part of this difference reflects the lower overall ambient levels of substance abuse in the Far East. But this explanation alone is insufficient because other types of illicit drug use are well documented there: opioids in China [40], methamphetamine, cannabis and opioids in Korea [41], or methamphetamine and inhalants in Japan [3]. Why then are AAS almost completely restricted to the West?
We suggest that the explanation dates back millennia and is grounded in psychosomatics. Western cultures have extolled muscularity since ancient times, as illustrated by Samson in the Bible, or by the supernaturally muscular gods of ancient Greece and Rome. Consider for example the ancient Farnese statue of Hercules, now at the Museo Archeologico Nazionale Napoli (http://www.marketplace.it/museo.nazionale/emuseo_home.htm) and depicted in a 17th-century drawing by famed Italian anatomist Bernardino Genga (fig. 2). Working centuries before AAS were discovered, Genga had never seen a real man who looked remotely like Hercules, yet his drawing eerily anticipates the modern AAS-using bodybuilder in figure 1b. The mythic traditions of Scandinavia – the region with perhaps the greatest contemporary epidemic of AAS use – arguably place an even stronger emphasis on muscularity, as exemplified by the gods of Norse mythology. Look, for example, at Füssli's 1788 painting of Thor battering the Midgard Serpent (fig. 3), based on the story in the medieval Prose Edda [42]. Like Genga, working long before the AAS era, Füssli had never seen an actual man who approached the proportions of the image that he painted – yet both Thor and his boatman Hymir, prone in the bow of the boat, look like AAS-using championship bodybuilders. These same venerable Western traditions of muscularity have continued to flourish into modern times, as illustrated by muscular action toys for children [43], male bodies in magazine advertisements [44], Hollywood movie characters [45] and numerous other images.
Fig. 2.

Drawing of the Farnese statue of Hercules from Bernardino Genga's Anatomia per uso et intelligenza del disegno (Rome, Domenico de Rossi, 1691). United States National Library of Medicine, Bethesda, Md., USA. From Historical Anatomies on the Web, plate 40. http://www.nlm.nih.gov/exhibition/historical anatomies/Images/1200_pixels/genga_40.jpg (accessed June 12, 2011).
Fig. 3.

Johann Heinrich Füssli's Der Kampf des Thor mit der Schlange des Midgard (Holland, 1788). Royal Academy of Arts, London, UK. http://en.wikipedia.org/wiki/File:Johann_Heinrich_F%C3%BCssli_011.jpg (accessed June 12, 2011).
By contrast, the cultural legacy of the Far East is almost devoid of these traditions or images. Compare, for example, the deity Izanagi (fig. 4), who with his sister Izanami created the islands of Japan in the Kojiki epic [46], or Japan's oldest known sculpture of Buddha, constructed in the year 609, at the Asuka-dera in Asuka (fig. 5). These deities are fully clothed, with no suggestion of enhanced muscularity. Similarly, in modern-day China or Japan, one rarely sees images of muscularity. The hero of an Asian action movie may be a lean martial artist, but not a muscle-bound hunk like Hollywood's Conan the Barbarian. These Eastern cultural traditions, like those of the West, hark back to ancient times. For example, as we have detailed elsewhere [47], the highly influential Analects of Confucius [48], written more than 2,000 years ago, link masculinity to intellect, refinement and virtuousness, but not to brawn.
Fig. 4.

Eitaku Kobayashi's Izanagi and Izanami (Japan, 1885). Museum of Fine Arts, Boston, Mass., USA. http://commons. wiki media.org/wiki/File:Kobayashi_Izanami_and_izanagi.jpg (accessed June 12, 2011).
Fig. 5.

Kuratsukuri-no-Tori's statue of Buddha at the Asuka-dera in Asuka, Japan (609 A.D.). http://en.wikipedia.org/wiki/File: Asuka_dera_daibutsu.jpg (accessed July 8, 2011).
The effects of these contrasting traditions are illustrated by the findings of recent studies using a computerized test of body image where college-age men were asked to select the male body that they thought was most appealing to women in their respective cultures. In response to this question, men in the USA, Austria and France selected a male image with about 10 kg more muscle than an average man in their societies [49], whereas men in Taiwan chose an image with very little added muscle, correctly recognizing that women were not attracted to a highly muscular male body [47] (fig. 6). This difference between East and West showed a striking effect size (Cohen's d = 0.9) [50], and it becomes even more impressive when one considers that many other types of body image concerns, by contrast, easily span cultural boundaries [51, 52]. In fact, young Japanese men actually appear to show higher levels of overall body dissatisfaction than their counterparts elsewhere [53, 54], even though they do not seem particularly dissatisfied with their muscles [55].
Fig. 6.
Discrepancy between the perceived muscularity of an ‘average man’ versus the muscularity of ‘the male body that women prefer the most’, as rated by men in the USA, France, Austria and Taiwan. Figure adapted, with permission, from Yang et al. [47].
Will body image drugs such as AAS eventually infiltrate the Far East? That will depend on whether Western attitudes towards muscularity, augmented by the forces of media and marketing, can trump the equally venerable opposing attitudes in Asia. Confucian traditions remain strong in East Asia [47], and we doubt that they will easily be overturned by the influences of Hollywood. Similarly, Eastern traditions of self-cultivation [56] such as Japanese shugyō – ‘forging the spirit’ through lengthy mental and physical training – may militate against the ‘easy’ path of simply taking a drug to alter one's body. Indeed, the very notion of merely enhancing the body while neglecting training of the mind or spirit is incompatible with longstanding traditions such as the bushi way in Japanese martial arts [57].
Nevertheless, looking at the somewhat analogous case of eating disorders, where body image concerns are in many ways the obverse of concerns about muscularity [58], we see that these disorders have begun to appear among men in Japan [59, 60] and China [61, 62], albeit more recently and less commonly than among men in Europe and America [63]. Clearly, cultural attitudes towards the body image are not static, and shifting global trends may well alter the distribution of body image drugs in future decades.
What about other forms of drug use? Unlike the body image drugs discussed in our example above, most other drugs of abuse are sought for their acute intoxicating effect, or ‘high’, and for millennia, cultures have helped to dictate peoples’ preferred intoxicant. In 430 B.C., for example, Herodotus documented the practice of the Persians to consider affairs of weight while drunk on alcohol; if they first made a decision while sober, they would later deliberately reconsider it under the influence of wine [64]. Conversely, many deeply spiritual traditional societies have long valued hallucinogenic plants – peyote, psilocybin mushrooms, ayahuasca or iboga – for their entheogenic effects [65, 66, 67]. One might speculate about countless other possible cultural influences. Perhaps achievement-oriented East Asians value the mentally ‘sharp’ high of methamphetamine more than, say, the mentally ‘dull’ high of cannabis [68]. Perhaps societies with high levels of anxiety breed more sedative-hypnotic drug abuse than societies without. Importantly, in any such comparison, one must also take into account possible cultural differences in willingness to disclose substance use [69]. All these issues remain little studied.
And what about new drugs on the horizon? Progress in pharmacology will likely yield not only new intoxicants, but also cognitive enhancers [70], drugs that may someday allow individuals to ‘dial’ their own body weight [71], and other substances with a variety of psychosomatic properties [72]. These and other drugs will increasingly be diffused on the Internet, with the consequent tendency towards a globalization of cultures [13, 73, 74, 75]. How, in the brave new world of expanding pharmacological options and growing electronic access, will people in different cultures choose from the menu available to them? These issues, and indeed many elements of our above discussion, remain speculative. Clearly, however, the interface between culture and drug abuse will remain a fertile area for future exploration, with implications for public health, international policy and ethics [76].
References
- 1.Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, Bruffaerts R, de Girolamo G, Gureje O, Huang Y, Karam A, Kostyuchenko S, Lepine JP, Mora ME, Neumark Y, Ormel JH, Pinto-Meza A, Posada-Villa J, Stein DJ, Takeshima T, Wells JE. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008;5:e141. doi: 10.1371/journal.pmed.0050141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Grelotti DJ, Kanayama G, Pope HG., Jr Remission of persistent methamphetamine- induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry. 2010;167:17–23. doi: 10.1176/appi.ajp.2009.08111695. [DOI] [PubMed] [Google Scholar]
- 3.Wada K, Ozaki S, Kondo A. Current situation of and the political measures for drug abuse/dependence (in Japanese) Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008;43:120–131. [PubMed] [Google Scholar]
- 4.Tominaga M, Kawakami N, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Naganuma Y, Furukawa TA, Hata Y, Kobayashi M, Miyake Y, Takeshima T, Kikkawa T. Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan: findings from the World Mental Health Japan Survey 2002–2004. Soc Psychiatry Psychiatr Epidemiol. 2009;44:777–783. doi: 10.1007/s00127-009-0499-1. [DOI] [PubMed] [Google Scholar]
- 5.Greberman SB, Wada K. Social and legal factors related to drug abuse in the United States and Japan. Public Health Rep. 1994;109:731–737. [PMC free article] [PubMed] [Google Scholar]
- 6.Kanayama G, Hudson JI, Pope HG., Jr Illicit anabolic-androgenic steroid use. Horm Behav. 2010;58:111–121. doi: 10.1016/j.yhbeh.2009.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kanayama G, Gruber AJ, Pope HG, Jr, Borowiecki JJ, Hudson JI. Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom. 2001;70:137–140. doi: 10.1159/000056238. [DOI] [PubMed] [Google Scholar]
- 8.Gruber AJ, Pope HG., Jr Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom. 2000;69:19–26. doi: 10.1159/000012362. [DOI] [PubMed] [Google Scholar]
- 9.Kouri EM, Pope HG, Jr, Katz DL, Oliva P. Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clin J Sport Med. 1995;5:223–228. doi: 10.1097/00042752-199510000-00003. [DOI] [PubMed] [Google Scholar]
- 10.Kanayama G, Hudson JI, Pope HG., Jr Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend. 2008;98:1–12. doi: 10.1016/j.drugalcdep.2008.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med Sci Sports Exerc. 2006;38:644–651. doi: 10.1249/01.mss.0000210194.56834.5d. [DOI] [PubMed] [Google Scholar]
- 12.Kanayama G, Pope HG, Jr, Hudson JI. ‘Body image’ drugs: a growing psychosomatic problem. Psychother Psychosom. 2001;70:61–65. doi: 10.1159/000056228. [DOI] [PubMed] [Google Scholar]
- 13.Brennan BP, Kanayama G, Hudson JI, Pope HG., Jr Illicit human growth hormone abuse in male weightlifters. Addict Behav. 2011;20:9–13. doi: 10.1111/j.1521-0391.2010.00093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hildebrandt T, Alfano L, Langenbucher JW. Body image disturbance in 1,000 male appearance- and performance-enhancing drug users. J Psychiatr Res. 2010;44:841–846. doi: 10.1016/j.jpsychires.2010.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM, Jr, Pope HG., Jr Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010;3:472–476. doi: 10.1161/CIRCHEARTFAILURE.109.931063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Pope HG, Jr, Katz DL. Psychiatric effects of exogenous anabolic-androgenic steroids. In: Wolkowitz OM, Rothschild AJ, editors. Psychoneuroendocrinology. The Scientific Basis of Clinical Practice. Washington: American Psychiatric Press; 2003. pp. 331–358. [Google Scholar]
- 17.Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG., Jr Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104:1966–1978. doi: 10.1111/j.1360-0443.2009.02734.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG., Jr Treatment of anabolic-androgenic steroid dependence: emerging evidence and its implications. Drug Alcohol Depend. 2010;109:6–13. doi: 10.1016/j.drugalcdep.2010.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Pope HG, Jr, Kean J, Nash A, Kanayama G, Samuel DB, Bickel WK, Hudson JI. A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validity. Exp Clin Psychopharmacol. 2010;18:203–213. doi: 10.1037/a0019370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nilsson S, Spak F, Marklund B, Baigi A, Allebeck P. Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescents in a county of Sweden. Subst Use Misuse. 2004;39:1183–1197. doi: 10.1081/ja-120030060. [DOI] [PubMed] [Google Scholar]
- 21.Pallesen S, Jøsendal O, Johnsen BH, Larsen S, Molde H. Anabolic steroid use in high school students. Subst Use Misuse. 2006;41:1705–1717. doi: 10.1080/10826080601006367. [DOI] [PubMed] [Google Scholar]
- 22.Skårberg K, Nyberg F, Engström I. Multisubstance use as a feature of addiction to anabolic-androgenic steroids. Eur Addict Res. 2009;15:99–106. doi: 10.1159/000199045. [DOI] [PubMed] [Google Scholar]
- 23.Thiblin I, Petersson A. Pharmacoepidemiology of anabolic androgenic steroids: a review. Fundam Clin Pharmacol. 2005;19:27–44. doi: 10.1111/j.1472-8206.2004.00298.x. [DOI] [PubMed] [Google Scholar]
- 24.Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE.Monitoring the future national survey results on drug use, 1975–2009. Vol II. College students and adults ages 19–50. NIH Publ No. 10-7585. Bethesda, National Institute on Drug Abuse, 2010. http://monitoringthefuture.org/new.html (accessed June 12, 2011).
- 25.McCabe SE, Brower KJ, West BT, Nelson TF, Wechsler H. Trends in non-medical use of anabolic steroids by US college students: results from four national surveys. Drug Alcohol Depend. 2007;90:243–251. doi: 10.1016/j.drugalcdep.2007.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Baker JS, Graham MR, Davies B. Steroid and prescription medicine abuse in the health and fitness community: a regional study. Eur J Intern Med. 2006;17:479–484. doi: 10.1016/j.ejim.2006.04.010. [DOI] [PubMed] [Google Scholar]
- 27.Copeland J, Peters R, Dillon P. A study of 100 anabolic-androgenic steroid users. Med J Aust. 1998;168:311–312. [PubMed] [Google Scholar]
- 28.Handelsman DJ, Gupta L. Prevalence and risk factors for anabolic-androgenic steroid abuse in Australian high school students. Int J Androl. 1997;20:159–164. doi: 10.1046/j.1365-2605.1997.d01-285.x. [DOI] [PubMed] [Google Scholar]
- 29.Goldfield GS, Woodside DB. Body image, disordered eating, and anabolic steroids in male bodybuilders: current versus former users. Phys Sportsmed. 2009;37:111–114. doi: 10.3810/psm.2009.04.1690. [DOI] [PubMed] [Google Scholar]
- 30.Melia P, Pipe A, Greenberg L. The use of anabolic-androgenic steroids by Canadian students. Clin J Sport Med. 1996;6:9–14. doi: 10.1097/00042752-199601000-00004. [DOI] [PubMed] [Google Scholar]
- 31.Galduróz JC, Noto AR, Nappo SA, Carlini EA. Household survey on drug abuse in Brazil: study involving the 107 major cities of the country – 2001. Addict Behav. 2005;30:545–556. doi: 10.1016/j.addbeh.2004.08.004. [DOI] [PubMed] [Google Scholar]
- 32.Kokkevi A, Fotiou A, Chileva A, Nociar A, Miller P. Daily exercise and anabolic steroids use in adolescents: a cross-national European study. Subst Use Misuse. 2008;43:2053–2065. doi: 10.1080/10826080802279342. [DOI] [PubMed] [Google Scholar]
- 33.Rachoń D, Pokrywka L, Suchecka-Rachoń K. Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz Praventivmed. 2006;51:392–398. doi: 10.1007/s00038-006-6018-1. [DOI] [PubMed] [Google Scholar]
- 34.Wanjek B, Rosendahl J, Strauss B, Gabriel HH. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med. 2007;28:346–353. doi: 10.1055/s-2006-924353. [DOI] [PubMed] [Google Scholar]
- 35.Takahashi M, Tatsugi T, Kohno Y. Telephone counseling of athletes abusing anabolic-androgenic steroids. J Sports Med Phys Fitness. 2007;47:356–360. [PubMed] [Google Scholar]
- 36.Takayanagi A, Kobayashi K, Hashimoto K, Kato R, Masumori N, Itoh N, Tsukamoto T. Case of androgenic-anabolic steroid abuse caused hypogonadotropic hypogonadism (in Japanese) Nippon Hinyokika Gakkai Zasshi. 2008;99:729–732. doi: 10.5980/jpnjurol1989.99.729. [DOI] [PubMed] [Google Scholar]
- 37.Takahashi M. A case of nail destruction as a possible side effect of anabolic-androgenic steroid doping (in Japanese) Nihon Tairyoku Igakkai. 1994;43:66–74. [Google Scholar]
- 38.Takahashi M. Gynecomastia as a side effect of anabolic-androgenic steroid doping in a Japanese amateur bodybuilder (in Japanese) Nihon Tairyoku Igakkai. 1996;45:237–244. [Google Scholar]
- 39.Yang CF, Gray PB, Zhang J, Pope HG., Jr Second to fourth digit ratios, sex differences, and behavior in Chinese men and women. Soc Neurosci. 2009;4:49–59. doi: 10.1080/17470910801942876. [DOI] [PubMed] [Google Scholar]
- 40.Lu L, Wang X. Drug addiction in China. Ann NY Acad Sci. 2008;1141:304–317. doi: 10.1196/annals.1441.025. [DOI] [PubMed] [Google Scholar]
- 41.Chung H, Park M, Hahn E, Choi H, Choi H, Lim M. Recent trends of drug abuse and drug-associated deaths in Korea. Ann N Y Acad Sci. 2004;1025:458–464. doi: 10.1196/annals.1316.056. [DOI] [PubMed] [Google Scholar]
- 42.Sturluson S. The Younger Edda, also called Snorre's Edda or the Prose Edda, transl by Anderson, RB. Chicago, Scott, Foresman. 1901 http://www.gutenberg.org/etext/18947 (accessed June 12, 2011) [Google Scholar]
- 43.Pope HG, Jr, Olivardia R, Gruber A, Borowiecki J. Evolving ideals of male body image as seen through action toys. Int J Eat Disord. 1999;26:65–72. doi: 10.1002/(sici)1098-108x(199907)26:1<65::aid-eat8>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
- 44.Pope HG, Jr, Olivardia R, Borowiecki JJ, Cohane GH. The growing commercial value of the male body: a longitudinal survey of advertising in women's magazines. Psychother Psychosom. 2001;70:189–192. doi: 10.1159/000056252. [DOI] [PubMed] [Google Scholar]
- 45.Pope HG, Jr, Phillips K, Olivardia R. The Secret Crisis of Male Body Obsession. New York: Simon and Schuster; 2000. The Adonis Complex. [Google Scholar]
- 46.Anonymous Kojiki. Record of Ancient Matters, transl by Chamberlain, BH. Rutland, Charles E Tuttle, 1981
- 47.Yang CF, Gray P, Pope HG., Jr Male body image in Taiwan versus the West: Yanggang Zhiqi meets the Adonis complex. Am J Psychiatry. 2005;162:263–269. doi: 10.1176/appi.ajp.162.2.263. [DOI] [PubMed] [Google Scholar]
- 48.Confucius: The Analects, transl by Lau, DC. New York, Penguin, 1979
- 49.Pope HG, Jr, Gruber AJ, Mangweth B, Bureau B, de Col C, Jouvent R, Hudson JI. Body image perception among men in three countries. Am J Psychiatry. 2000;157:1297–1301. doi: 10.1176/appi.ajp.157.8.1297. [DOI] [PubMed] [Google Scholar]
- 50.Kanayama G, Pope HG., Jr Gods, men, and muscle dysmorphia. Harv Rev Psychiatry. 2011;19:95–98. doi: 10.3109/10673229.2011.565250. [DOI] [PubMed] [Google Scholar]
- 51.Fava GA. Morselli's legacy: dysmorphophobia. Psychother Psychosom. 1992;58:117–118. doi: 10.1159/000288619. [DOI] [PubMed] [Google Scholar]
- 52.Snaith P. Body image disorders. Psychother Psychosom. 1992;58:119–124. doi: 10.1159/000288620. [DOI] [PubMed] [Google Scholar]
- 53.Kowner R. When ideals are too ‘far off’: physical self-ideal discrepancy and body dissatisfaction in Japan. Genet Soc Gen Psychol Monogr. 2004;130:333–361. doi: 10.3200/MONO.130.4.333-364. [DOI] [PubMed] [Google Scholar]
- 54.Lerner RM, Iwawaki S, Chihara T, Sorell GT. Self-concept, self-esteem, and body attitudes among Japanese male and female adolescents. Child Dev. 1980;51:847–855. [Google Scholar]
- 55.Sano A, Le DS, Tran MH, Pham HT, Kaneda M, Murai E, Kamiyama H, Oota Y, Yamamoto S. Study on factors of body image in Japanese and Vietnamese adolescents. J Nutr Sci Vitaminol (Tokyo) 2008;54:169–175. doi: 10.3177/jnsv.54.169. [DOI] [PubMed] [Google Scholar]
- 56.Yuasa Y.The Body, Self-Cultivation, and Ki-Energy, transl by Nagamoto S, Hull M. Albany, State University of New York Press, 1993
- 57.Minamoto R. A study of practical learning in the beginning of the modern period (in Japanese) Tokyo: Sō bunsha; 1980. [Google Scholar]
- 58.Mangweth B, Pope HG, Jr, Kemmler G, Ebenbichler C, Hausmann A, de Col C, Kreutner B, Kinzl J, Biebl W. Body image and psychopathology in male bodybuilders. Psychother Psychosom. 2001;70:38–43. doi: 10.1159/000056223. [DOI] [PubMed] [Google Scholar]
- 59.Chisuwa N, O'Dea JA. Body image and eating disorders amongst Japanese adolescents: a review of the literature. Appetite. 2010;54:5–15. doi: 10.1016/j.appet.2009.11.008. [DOI] [PubMed] [Google Scholar]
- 60.Kayano M, Yoshiuchi K, Al-Adawi S, Viernes N, Dorvlo AS, Kumano H, Kuboki T, Akabayashi A. Eating attitudes and body dissatisfaction in adolescents: cross-cultural study. Psychiatry Clin Neurosci. 2008;62:17–25. doi: 10.1111/j.1440-1819.2007.01772.x. [DOI] [PubMed] [Google Scholar]
- 61.Chen H, Jackson T. Prevalence and sociodemographic correlates of eating disorder endorsements among adolescents and young adults from China. Eur Eat Disord Rev. 2008;16:375–385. doi: 10.1002/erv.837. [DOI] [PubMed] [Google Scholar]
- 62.Tong J, Miao SJ, Wang J, Zhang JJ, Wu HM, Li T, Hsu LK. Five cases of male eating disorders in Central China. Int J Eat Disord. 2005;37:72–75. doi: 10.1002/eat.20061. [DOI] [PubMed] [Google Scholar]
- 63.Mangweth B, Pope HG, Jr, Hudson JI, Olivardia R, Kinzl J, Biebl W. Eating disorders in Austrian men: an intracultural and crosscultural comparison study. Psychother Psychosom. 1997;66:214–221. doi: 10.1159/000289137. [DOI] [PubMed] [Google Scholar]
- 64.Herodotus Readings in Ancient History, vol I, transl by Rawlinson G. Boston, Allyn and Bacon, 1912
- 65.Halpern JH. Hallucinogens: an update. Curr Psychiatry Rep. 2003;5:347–354. doi: 10.1007/s11920-003-0067-4. [DOI] [PubMed] [Google Scholar]
- 66.Halpern JH, Sherwood AR, Hudson JI, Yurgelun-Todd D, Pope HG., Jr Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry. 2005;58:624–631. doi: 10.1016/j.biopsych.2005.06.038. [DOI] [PubMed] [Google Scholar]
- 67.Pope HG., Jr Tabernanthe iboga: an African narcotic plant of social importance. Econ Bot. 1969;23:174–184. [Google Scholar]
- 68.Suwaki H. Substance-abuse trends in Japan. Public Health Rev. 1983;11:199–222. [Google Scholar]
- 69.Fendrich M, Johnson TP. Race/ethnicity differences in the validity of self-reported drug use: results from a household survey. J Urban Health. 2005;82(suppl 3):iii67–iii81. doi: 10.1093/jurban/jti065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature. 2008;456:702–705. doi: 10.1038/456702a. [DOI] [PubMed] [Google Scholar]
- 71.Kennett GA, Clifton PG. New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier? Pharmacol Biochem Behav. 2010;97:63–83. doi: 10.1016/j.pbb.2010.07.020. [DOI] [PubMed] [Google Scholar]
- 72.Cyranoski D. Malaysian researchers bet big on home-grown Viagra. Nat Med. 2005;11:912. doi: 10.1038/nm0905-912a. [DOI] [PubMed] [Google Scholar]
- 73.Deluca P, Schifano F. Searching the Internet for drug-related web sites: analysis of online available information on ecstasy (MDMA) Am J Addict. 2007;16:479–483. doi: 10.1080/10550490701641181. [DOI] [PubMed] [Google Scholar]
- 74.Fox N, Ward K, O'Rourke A. Pro-anorexia, weight-loss drugs and the internet: an ‘anti-recovery’ explanatory model of anorexia. Sociol Health Illn. 2005;27:944–971. doi: 10.1111/j.1467-9566.2005.00465.x. [DOI] [PubMed] [Google Scholar]
- 75.Halpern JH, Pope HG., Jr Hallucinogens on the Internet: a vast new source of underground drug information. Am J Psychiatry. 2001;158:481–483. doi: 10.1176/appi.ajp.158.3.481. [DOI] [PubMed] [Google Scholar]
- 76.Hesse M. Enhancement drugs: are there limits to what we should enhance and why? BMC Med. 2010;8:50. doi: 10.1186/1741-7015-8-50. [DOI] [PMC free article] [PubMed] [Google Scholar]


